GPNMB and cancer: Future studies should aim at validating GPNMB and CHI3L1 not only as markers of OCSC but also as causal players in OCSC-driven tumor progression and as putative targets in the context of tumor-eradicating strategies based on the elimination of the cancer stem cell subpopulation.